CRB-65 for the assessment of pneumonia severity: Who could ask for more?

Thorax

Volumn 63, Issue 8, 2008, Pages 665-666

  Ewig, Santiago ^a   Welte, Tobias ^b  

^a Augusta Kranken Anstalt   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROADRENOMEDULLIN; PROCALCITONIN;

CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL PATHWAY; COMMUNITY ACQUIRED PNEUMONIA; CRB 65 SCORING SYSTEM; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; FRAIL ELDERLY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LONG TERM CARE; LOWER RESPIRATORY TRACT INFECTION; NURSING HOME; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

EID: 49149091451     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2008.099028     Document Type: Editorial

References (25)

1. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
2. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax 2000;55:219-23.
3. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
4. Ewig S, de Roux A, Bauer T, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004;59:421-7.
5. Bauer TT, Ewig S, Marre R, et al. The CAPNETZ Study Group: CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006;260:93-101.
6. Capelastegui A, España PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006;27:151-7.
7. Ewig S, Torres A, Woodhead M. Assessment of pneumonia severity: a European perspective. Eur Respir J 2006;27:6-8.
8. Chalmers JD, Singanayagam A, Hill AT. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 2008;63:698-702.
9. Leff B, Burton L, Mader SL, et al. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med 2005;143:798-808.
10. Torres OH, Muñoz J, Ruiz D, et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc 2004;52:1603-9.
11. Inouye SK, Peduzzi PN, Robison JT, et al. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 1998;279:1187-93.
12. Sager MA, Rudberg MA, Jalaluddin M, et al. Hospital admission risk profile (HARP): identifying older patients at risk for functional decline following acute medical illness and hospitalization. J Am Geriatr Soc 1996;44:251-7.
13. El Solh A, Pineda L, Bouquin P, et al. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr 2006;6:12.
14. Mody L, Sun R, Bradley SF. Assessment of pneumonia in older adults: effect of functional status. J Am Geriatr Soc 2006;54:1062-7.
15. Kruse RL, Mehr DR, Boles KE, et al. Does hospitalization impact survival after lower respiratory infection in nursing home residents? Med Care 2004;42:860-70.
16. Fried TR, Gillick MR, Lipsitz LA. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia. J Gen Intern Med 1995;10:246-50.
17. Loeb M, Carusone SC, Goeree R, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA 2006;295:2503-10.
18. Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J Am Geriatr Soc 1997;45:302-6.
19. Degelau J, Guay D, Straub K, et al. Effectiveness of oral antibiotic treatment in nursing home-acquired pneumonia. J Am Geriatr Soc 1995;43:245-51.
20. Marrie TJ, Fine MJ, Kapoor WN, et al. Community-acquired pneumonia and do not resuscitate orders. J Am Geriatr Soc 2002;50:290-9.
21. Christ-Crain M, Müller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007;30:556-73.
22. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006;174:84-93.
23. Krüger S, Ewig S, Marre R, et al on behalf of the CAPNETZ study group. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31:349-55.
24. Christ-Crain M, Morgenthaler NG, Stolz D, et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia. Crit Care 2006;10:R96.
25. Krüger S, Papassotiriou J, Marre R, et al. CAPNETZ Study Group. Pro-atrial natriuretic peptide and provasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 2007;33:2069-78.